Sort   by:  
 Page size 
TranscriptomicsGene expression profiling of cidofovir treatment and resistance inHeLa, HaCaT, and PHK cells
Cidofovir is an acyclic nucleoside phosphonate with strong antiviral activity against a broad spectrum of DNA viruses. Although it has previously been shown that cidofovir exerts an antiproliferative effect on HPV positive cells by the induction of apoptosis, the exact mechanism of action remains to...
ORGANISM(S): Homo sapiens 
2013-07-03 | E-GEOD-39293 | biostudies-arrayexpress
TranscriptomicsGene expression profiling of cidofovir treatment and resistance in SiHa cells
Cidofovir is an acyclic nucleoside phosphonate with strong antiviral activity against a broad spectrum of DNA viruses. Although it has previously been shown that cidofovir exerts an antiproliferative effect on HPV positive cells by the induction of apoptosis, the exact mechanism of action remains to...
ORGANISM(S): Homo sapiens 
2013-01-31 | GSE26748 | GEO
TranscriptomicsGene expression profiling of cidofovir treatment and resistance inHeLa, HaCaT, and PHK cells
Cidofovir is an acyclic nucleoside phosphonate with strong antiviral activity against a broad spectrum of DNA viruses. Although it has previously been shown that cidofovir exerts an antiproliferative effect on HPV positive cells by the induction of apoptosis, the exact mechanism of action remains to...
ORGANISM(S): Homo sapiens 
2013-07-03 | GSE39293 | GEO
ProteomicsProteome characterization of HCMV virus microenvironment with addition of cidofovir
The control of host processes which influence cell-cell communication is central to determining the outcome of a virus infection in tissue. Despite this, it remains unclear how cells either in close or distant proximity to an infected cell differentially respond to the primary infection. Here, we es...
ORGANISM(S): Homo sapiens (Human) 
2023-05-11 | PXD040582 | Pride
Hcmv Innate immunity Membrane contact sites Mass spectrometry Virus microenvironment Cell cycle Cidofovir 
GenomicsHomo sapiens
Gene expression profiling of cidofovir treatment and resistance in SiHa cells
PRJNA136337 | ENA
TranscriptomicsSerial time induction by TPA on BCBL-1 cells in the absence or presence of viral replication inhibitor cidofovir
BCBL-1 cells were induced with 20 ng/ml TPA either in the absence (U) or presence (+) of 100 µM cidofovir (CDV) treatment and collected at 0, 6, 8, 10, 12, 24, 36, 48, 72, 96 hours (h) post-TPA addition, and compared against untreated (U), uninduced latent BCBL-1 reference cells. Three biological re...
ORGANISM(S): Homo sapiens Human gammaherpesvirus 8 
2004-12-01 | GSE1640 | GEO
GenomicsHomo sapiens
Gene expression profiling of cidofovir treatment and resistance inHeLa, HaCaT, and PHK cells
PRJNA170506 | ENA
UnknownAdenovirus pneumonia treated with Cidofovir in an immunocompetent high school senior.
Not available
S-EPMC6354651 | biostudies-literature
UnknownUse of cidofovir in a patient with severe mpox and uncontrolled HIV infection.
Not available
S-EPMC9908088 | biostudies-literature
UnknownOutcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia.
Not available
S-EPMC4398328 | biostudies-literature
Sort   by:  
 Page size